Picard Medical (PMI) Research & Development (2024 - 2026)

Picard Medical has reported Research & Development for 3 years, with the latest figure at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 134.53% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $4.1 million (up 18.24% YoY), and the FY2025 full-year result was $3.0 million, down 9.79% from the prior year.
• Research & Development for Q1 2026 stood at $1.9 million, up from $547000.0 in the prior quarter.
• The five-year high for Research & Development was $1.9 million in Q1 2026, with the low at $547000.0 in Q4 2025.
• Historically, Research & Development has averaged $954250.0 across 3 years, with a median of $874000.0 in 2024.
• Annual changes were most pronounced in 2025 — Research & Development tumbled 30.67% — and 2026, when it soared 134.53%.
• Picard Medical's Research & Development stood at $789000.0 in 2024, then tumbled by 30.67% to $547000.0 in 2025, then jumped by 246.44% to $1.9 million in 2026.
• The last three Research & Development figures came in at $1.9 million (Q1 2026), $547000.0 (Q4 2025), and $951000.0 (Q3 2025), per Business Quant data.